Protective effects of tanshinone IIA on sepsis-induced multiple organ dysfunction: a literature review

被引:0
|
作者
Lili, Wang [1 ,2 ]
Ju, Feng [1 ,2 ]
Daqian, Zhan [1 ,2 ]
Junshuai, Wang [1 ,2 ]
Daixing, Zhou [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Emergency Dept, Wuhan 430030, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Intens Care Unit, Wuhan 430030, Peoples R China
关键词
tanshinoneIIA; sepsis; multiple organ failure; review; DISSEMINATED INTRAVASCULAR COAGULATION; ATTENUATES CARDIAC DYSFUNCTION; ACUTE KIDNEY INJURY; ACUTE LUNG INJURY; MICROCIRCULATORY DISTURBANCE; SMALL-INTESTINE; SEPTIC SHOCK; SULFONATE; INFLAMMATION; MICE;
D O I
10.19852/j.cnki.jtcm.20230727.003
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Tanshinone II A (Tan II A) is a noteworthy lipophilic diterpene compound derived from the dried roots of the Traditional Chinese Medicine Danshen (Radix Salviae Miltiorrhizae) that has various pharmacological properties, including anti-inflammatory, antibacterial, and antioxidative effects. Sepsis is a life-threatening organ dysfunction induced by a dysregulated host response to infection. Recently, increasing attention has been paid to sepsis-induced dysfunction of the intestine, cardiovascular system, lungs, kidneys, liver, and other organs. Experimental studies have shown that Tan II A has therapeutic potential for sepsis-induced organ dysfunction owing to its anti-inflammatory, anti-apoptotic and regulatory effects on multiple signalling pathways. The purpose of this article is to evaluate the potential multiorgan protective effects of TanIIA in sepsis.(c) 2023 JTCM. All rights reserved.
引用
收藏
页码:1040 / 1046
页数:7
相关论文
共 50 条
  • [41] Early potassium channel blockade improves sepsis-induced organ damage and cardiovascular dysfunction
    Sordi, R.
    Fernandes, D.
    Heckert, B. T.
    Assreuy, J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (06) : 1289 - 1301
  • [42] Sepsis-induced brain dysfunction
    Adam, Nicolas
    Kandelman, Stanislas
    Mantz, Jean
    Chretien, Fabrice
    Sharshar, Tarek
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (02) : 211 - 221
  • [43] Sepsis-induced myocardial dysfunction
    Walley, Keith R.
    CURRENT OPINION IN CRITICAL CARE, 2018, 24 (04) : 292 - 299
  • [44] Sepsis-Induced myocardial dysfunction: heterogeneity of functional effects and clinical significance
    Shvilkina, Tatyana
    Shapiro, Nathan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [45] The molecular mechanism of sepsis-induced diaphragm dysfunction
    Yuan, Xiaosa
    Xue, Fangsu
    Yu, Yunchi
    Cao, Xiaowen
    Han, Yimin
    Wang, Fei
    Zhong, Lou
    JOURNAL OF THORACIC DISEASE, 2023, 15 (12) : 6831 - 6847
  • [46] Protective effect of phosphatidylserine blockade in sepsis induced organ dysfunction
    Beattie, Genna
    Cohan, Caitlin
    Miraflor, Emily
    Brigode, William
    Victorino, Gregory P.
    SURGERY, 2019, 166 (05) : 844 - 848
  • [47] Upregulation of miR-335 exerts protective effects against sepsis-induced myocardial injury
    Long, Xian
    Huang, Yongpan
    He, Jianbin
    Zhang, Xiang
    Zhou, Yan
    Wei, Yingmin
    Tang, Ying
    Liu, Lijing
    MOLECULAR MEDICINE REPORTS, 2021, 24 (05)
  • [48] Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis
    Suzuki, Takeshi
    Suzuki, Yuta
    Okuda, Jun
    Kurazumi, Takuya
    Suhara, Tomohiro
    Ueda, Tomomi
    Nagata, Hiromasa
    Morisaki, Hiroshi
    JOURNAL OF INTENSIVE CARE, 2017, 5
  • [49] Expression of MicroRNAs in Sepsis-Related Organ Dysfunction: A Systematic Review
    Maiese, Aniello
    Scatena, Andrea
    Costantino, Andrea
    Chiti, Enrica
    Occhipinti, Carla
    La Russa, Raffaele
    Di Paolo, Marco
    Turillazzi, Emanuela
    Frati, Paola
    Fineschi, Vittorio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [50] Year in review 2010: Critical Care - multiple organ dysfunction and sepsis
    Etienne de Montmollin
    Djillali Annane
    Critical Care, 15